All Merck articles
-
NewsStudy reveals how gut microbes can distinguish prion disease in deer
A new collaborative study sheds light on how chronic wasting disease in deer impacts the gut microbiome and provides a potential tool for disease surveillance.
-
NewsTreatment with enzyme inhibitor can help combat antimicrobial resistance
Researchers have shown that intravenous treatment with MK-3402, a metallo-beta-lactamase inhibitor, can be an effective strategy in fighting antimicrobial resistance.
-
NewsWarning over lack of ‘substantial evidence’ for FDA approved antibiotic
Drugs approved in the US require “substantial evidence” that they are effective, but an investigation by The BMJ into the recent approval of the antibiotic Recarbrio from Merck suggests that these standards are being bypassed.
